Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Treasury Shares (2019 - 2025)

Korro Bio's Treasury Shares history spans 6 years, with the latest figure at $506981.0 for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed N/A year-over-year to $506981.0, compared with a TTM value of $506981.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $506981.0, changed N/A over the prior year.
  • Treasury Shares for Q4 2025 was $506981.0 at Korro Bio, down from $1.9 million in the prior quarter.
  • The five-year high for Treasury Shares was $3.6 million in Q1 2023, with the low at $2629.0 in Q1 2021.
  • Average Treasury Shares over 4 years is $1.4 million, with a median of $779900.0 recorded in 2021.
  • Biggest YoY gain for Treasury Shares was 82264.02% in 2022; the steepest drop was 99.54% in 2022.
  • Tracing KRRO's Treasury Shares over 4 years: stood at $626300.0 in 2021, then tumbled by 99.54% to $2902.0 in 2022, then soared by 66411.03% to $1.9 million in 2023, then plummeted by 73.73% to $506981.0 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Treasury Shares are $506981.0 (Q4 2025), $1.9 million (Q3 2023), and $3.1 million (Q2 2023).